In December 2025, Novo Nordisk India and Healthify announced a collaboration to launch a comprehensive AI-powered obesity patient support programme across the country. Under the new arrangement, Healthify’s AI-based health-coach, Ria, will help users manage their nutrition, lifestyle and follow-up care, while offering tailored guidance throughout their weight-management journey. The initiative targets individuals living with obesity or overweight, aiming to improve consistency in treatment, encourage healthier habits, and support long-term wellness. 

The programme is positioned as a holistic adjunct to pharmacological therapy: Novo Nordisk, already a player in obesity drugs, emphasizes that sustainable outcomes require structured lifestyle support  not just medication. By embedding an AI-driven coaching and monitoring layer, the partnership hopes to bridge gaps in adherence, patient education, and long-term behavioural change. its existing user base, AI and human-coach hybrid model, and digital infrastructure  enabling scalable, personalised obesity-care support across India. The collaboration also reflects growing convergence between pharma and healthtech to address chronic lifestyle diseases through integrated care models combining drugs, coaching, and digital tools.